Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator — Seiko Ishida (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Shared by
Douglas Hanahan
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Article
2010
en
Authors
+1 more
SI
Seiko Ishida
FM
Frank McCormick
KS
Karen Smith‐McCune
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2008
The dilemma of anticancer therapy: tumor-specific versus immune effects
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2015
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani
,
Paola Allavena
Article
2010
Envisioning the future of early anticancer drug development
Timothy A. Yap
,
Shahneen Sandhu
,
Paul Workman
,
Johann S. de Bono
Article
2024
Enhancing CAR-T Cell Therapy Against Solid Tumor by Drug-Free Triboelectric Immunotherapy
Haimei Li
,
Zichen Wang
,
Yulin Hu
,
Guangqin He
,
Liang Huang
,
Yi Liu
,
Zhong Lin Wang
,
Peng Jiang
Article
2019
Tumor lysis with LTX-401 creates anticancer immunity
Wei Xie
,
Laura Mondragón
,
Brynjar Mauseth
,
Yan Wang
,
Jonathan Pol
,
Sarah Lévesque
,
Heng Zhou
,
Takahiro Yamazaki
,
J. Johannes Eksteen
,
Laurence Zitvogel
,
Baldur Sveinbjørnsson
,
Øystein Rekdal
,
Oliver Kepp
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.